Ozon Pharmaceuticals introduced Cruoxaban with the active substance Rivaroxaban - a generic of the best-selling foreign drug. Its sales volume for 9 months of 2024 exceeded ₽13 billion. To date, more than 400 thousand packs of the generic have already been shipped.